- Home
- RENB vs PETS Comparison
RENB vs PETS Comparison
Compare RENB & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENB
- PETS
- Stock Information
- Founded
- RENB 2011
- PETS 1996
- Country
- RENB United States
- PETS United States
- Employees
- RENB N/A
- PETS N/A
- Industry
- RENB Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- RENB Health Care
- PETS Consumer Staples
- Exchange
- RENB Nasdaq
- PETS Nasdaq
- Market Cap
- RENB 121.3M
- PETS 105.6M
- IPO Year
- RENB N/A
- PETS N/A
- Fundamental
- Price
- RENB $0.35
- PETS $3.09
- Analyst Decision
- RENB
- PETS Sell
- Analyst Count
- RENB 0
- PETS 2
- Target Price
- RENB N/A
- PETS $3.35
- AVG Volume (30 Days)
- RENB 855.6K
- PETS 217.6K
- Earning Date
- RENB 05-14-2025
- PETS 06-10-2025
- Dividend Yield
- RENB N/A
- PETS N/A
- EPS Growth
- RENB N/A
- PETS N/A
- EPS
- RENB N/A
- PETS 0.02
- Revenue
- RENB N/A
- PETS $247,010,000.00
- Revenue This Year
- RENB N/A
- PETS N/A
- Revenue Next Year
- RENB N/A
- PETS N/A
- P/E Ratio
- RENB N/A
- PETS $181.08
- Revenue Growth
- RENB N/A
- PETS N/A
- 52 Week Low
- RENB $0.32
- PETS $2.90
- 52 Week High
- RENB $2.70
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- RENB 29.29
- PETS 29.92
- Support Level
- RENB $0.35
- PETS $2.99
- Resistance Level
- RENB $0.39
- PETS $4.28
- Average True Range (ATR)
- RENB 0.07
- PETS 0.20
- MACD
- RENB -0.00
- PETS -0.04
- Stochastic Oscillator
- RENB 11.00
- PETS 9.16
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.